Study of EO-3021 in Adult Patients With Solid Tumors Likely to Express CLDN18.2
Elevation Oncology
Elevation Oncology
Hoffmann-La Roche
Thomas Jefferson University
Thomas Jefferson University
Boston Scientific Corporation
Pfizer
Imunon
NanOlogy, LLC
Theseus Pharmaceuticals
Kyowa Kirin Co., Ltd.
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc.
Celgene
H. Lee Moffitt Cancer Center and Research Institute
Novartis
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Isofol Medical AB
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Novartis
Yale University
Exact Sciences Corporation
Novartis
Pfizer